FI953141A0 - Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi - Google Patents

Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi

Info

Publication number
FI953141A0
FI953141A0 FI953141A FI953141A FI953141A0 FI 953141 A0 FI953141 A0 FI 953141A0 FI 953141 A FI953141 A FI 953141A FI 953141 A FI953141 A FI 953141A FI 953141 A0 FI953141 A0 FI 953141A0
Authority
FI
Finland
Prior art keywords
cells
isolation
purification
produced
hiv glycoprotein
Prior art date
Application number
FI953141A
Other languages
English (en)
Swedish (sv)
Other versions
FI953141A (fi
FI97058B (fi
FI97058C (fi
Inventor
Johann Eibl
Friedrich Dorner
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI953141A publication Critical patent/FI953141A/fi
Publication of FI953141A0 publication Critical patent/FI953141A0/fi
Publication of FI97058B publication Critical patent/FI97058B/fi
Application granted granted Critical
Publication of FI97058C publication Critical patent/FI97058C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
FI953141A 1987-12-23 1995-06-22 Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi FI97058C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP87119172 1987-12-23
EP87119172A EP0321606B1 (de) 1987-12-23 1987-12-23 Zelluläre amphipatische Proteine in aggregierten Formen und Verfahren zur Herstellung und Reinigung diese Proteine

Publications (4)

Publication Number Publication Date
FI953141A FI953141A (fi) 1995-06-22
FI953141A0 true FI953141A0 (fi) 1995-06-22
FI97058B FI97058B (fi) 1996-06-28
FI97058C FI97058C (fi) 1996-10-10

Family

ID=8197541

Family Applications (2)

Application Number Title Priority Date Filing Date
FI885629A FI96864C (fi) 1987-12-23 1988-12-02 Ei-terapeuttisesti käytettävä HIV:n glykoproteiini GP 160 ja menetelmä sen valmistamiseksi
FI953141A FI97058C (fi) 1987-12-23 1995-06-22 Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI885629A FI96864C (fi) 1987-12-23 1988-12-02 Ei-terapeuttisesti käytettävä HIV:n glykoproteiini GP 160 ja menetelmä sen valmistamiseksi

Country Status (8)

Country Link
EP (1) EP0321606B1 (fi)
JP (1) JP2656098B2 (fi)
AT (1) ATE95188T1 (fi)
DE (1) DE3787654D1 (fi)
DK (1) DK628188A (fi)
ES (1) ES2059355T3 (fi)
FI (2) FI96864C (fi)
NO (1) NO175782C (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672895B1 (fr) * 1991-02-15 1995-05-12 Transgene Sa Procede de purification d'une proteine fortement glycosylee.
FR2692898B1 (fr) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
US5914390A (en) * 1997-05-12 1999-06-22 Celtrix Pharmaceuticals, Inc. Methods for increasing yields of recombinant proteins
DE19939246A1 (de) 1999-08-19 2001-02-22 Phasys Gmbh M Rückfaltung von Membranproteinen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61233700A (ja) * 1984-12-24 1986-10-17 ジエネンテク，インコ−ポレイテツド 分子クロ−ンされたエイズ関連ポリペプチド
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
JPS62198627A (ja) * 1986-02-26 1987-09-02 Biseibutsu Kagaku Kenkyusho:Kk オ−エスキ−病可溶化抗原ワクチン

Also Published As

Publication number Publication date
NO175782B (no) 1994-08-29
ES2059355T3 (es) 1994-11-16
FI953141A (fi) 1995-06-22
FI885629A (fi) 1989-06-24
EP0321606A1 (de) 1989-06-28
NO885738D0 (no) 1988-12-23
DK628188A (da) 1989-06-24
FI96864B (fi) 1996-05-31
FI96864C (fi) 1996-09-10
DE3787654D1 (de) 1993-11-04
ATE95188T1 (de) 1993-10-15
NO885738L (no) 1989-06-26
FI97058B (fi) 1996-06-28
JPH02798A (ja) 1990-01-05
FI97058C (fi) 1996-10-10
EP0321606B1 (de) 1993-09-29
FI885629A0 (fi) 1988-12-02
JP2656098B2 (ja) 1997-09-24
DK628188D0 (da) 1988-11-10
NO175782C (no) 1994-12-07

Similar Documents

Publication Publication Date Title
DK161943C (da) Katalysator paa basis af silicium og titan, fremgangsmaade til fremstilling heraf, samt anvendelse af katalysatoren ved epoxidering af olefiner eller ved indfoerelse af hydroxygrupper i aromater
IT1177783B (it) Materiali amorfi resistenti all'usura ed articoli prodotti con essi,nonche' procedimento per la loro fabbricazione
IT8421580A0 (it) Contenitore e metodo per il lavaggio e l'integrazione operativa del funzionamento di circuiti e filtri per dialisi.
IT8819009A0 (it) Procedimento perfezionato per laproduzione di riso ibrido.
FI864267A (fi) Modifierad process foer satsvis rening av sio2 i naerliggande fraktioner.
FR2565985B1 (fr) Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
DE59610319D1 (de) Entfernen von Viren durch Ultrafiltration aus Proteinlösungen
DK245184D0 (da) Kul-vand-blandinger omfattende ikke-ioniske og anioniske overfladeaktive stoffer
NO872099D0 (no) Anordning ved sentralt stoevsugersystem.
FI953141A0 (fi) Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi
DE3484212D1 (de) Hybride dns-synthese von reifem wachstumshormonausloesendem faktor.
DE3672251D1 (de) Herstellung von cholecalciferolderivaten und neue hierfuer verwendete zwischenprodukte.
IT8423424A0 (it) Processo per la preparazione di (2,2)-paraciclofano.
DE3885686T2 (de) Reinigungsverfahren.
IT8320842A0 (it) Processo per la produzione dimateriale cementizio a partire da fanghi di lavorazione industriali e urbani.
IT8621465A0 (it) Processo per la trans-alogenazione catalitica di un poli-iodo benzene.
FI933408A (fi) Ksylanas, ksylanas producerande bacillus-stammar samt deras utnyttjande
EP0076696A3 (en) A restriction enzyme and a method for production thereof
NO871286D0 (no) Maskineringssystem for tynnplatematerialer.
AU3185384A (en) Process for producing 1,3-bis(3-aminophenoxy) benzene
JPS6428A (en) Prophylactic and remedy for horse infections
DE3875268T2 (de) Trennungsverfahren von cyclohexanol.
ES483485A1 (es) Metodo de utilizar el desperdicio que se origina por frac- cionacion del papel de recuperacion
IT1209606B (it) Processo per la preparazione di isossazoli 3,5-disostituiti.
IT8323989A0 (it) Processo per la produzione dichetoni alifatici superiori in stadio singolo.

Legal Events

Date Code Title Description
BB Publication of examined application